The University of Chicago Header Logo

Connection

John LaMattina to Immunoconjugates

Back to Details
This is a "connection" page, showing publications John LaMattina has written about Immunoconjugates.
John LaMattina
Connection Strength
0.433
Immunoconjugates
  1. Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation. 2014 Jan 27; 97(2):133-7.
    View in: PubMed
    Score: 0.433
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.